ASTH Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio62.56Forward 23.04
EPS (TTM)$0.61110.1% YoY
Profit margin0.9%HEALTHCARE
Market cap$1.89BSmall cap
Wall Street coverage
$46.00median target· current $40.55 (+13.4%)11 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 23.04
- PEG ratio
- 0.00
- P/B
- 2.38
- P/S (TTM)
- 0.54
- EV/EBITDA
- 15.29
Profitability & growth
- ROE (TTM)
- 5.7%
- Operating margin
- 3.0%
- Revenue growth YoY
- 55.6%
- Dividend yield
- —
- Beta
- 0.94
Last earnings
May 7, 2026 · Estimate $0.65 · Reported $0.74
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Astrana Health Inc
Company profileAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1668 S. GARFIELD AVENUE, ALHAMBRA, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$1.89B
Shares outstanding$49.6M
52W high$40.13
52W low$18.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent